AutoimmuneICD-10: M05-M06About 1.3 million adults in the US; approximately 0.5–1% of the global population

Rheumatoid Arthritis

Also known as: RA

Rheumatoid arthritis (RA) is a chronic autoimmune disorder that primarily attacks the synovial lining of the joints, causing painful swelling that can eventually lead to joint destruction, deformity, and disability. Unlike osteoarthritis, RA is a systemic disease that can also affect the heart, lungs, eyes, and blood vessels. Early aggressive treatment with disease-modifying drugs has revolutionized outcomes for people with RA.

Last updated October 31, 2026

Understanding Rheumatoid Arthritis

Rheumatoid arthritis is an autoimmune disease in which the immune system turns against the synovium, the thin membrane lining joints, and keeps attacking it for life unless treatment holds it back. It affects roughly 0.5 to 1 percent of adults, women two to three times more often than men, and most commonly begins between 30 and 60. The hallmark is symmetrical swelling of the small joints of the hands, wrists and feet with morning stiffness that lasts an hour or more, but it is a whole-body illness: profound fatigue, anaemia, dry eyes, lung inflammation and a cardiovascular risk roughly equal to that of type 2 diabetes come with it. It is not a worse version of osteoarthritis; it is a different disease.

In susceptible people, often carrying HLA-DRB1 'shared epitope' genes and exposed to smoking or gum disease, the immune system begins reacting to the body's own proteins that have been chemically modified by citrullination. Anti-CCP antibodies can be found in blood years before joints hurt. Once the synovium is targeted, it thickens into an invasive tissue called pannus packed with macrophages, T and B cells that pour out TNF, interleukin-6 and interleukin-1. These cytokines activate osteoclasts that bore into bone at the joint margins, producing the erosions seen on X-ray, and degrade cartilage. The same inflammation stiffens arteries, which is why heart attack risk is raised and why controlling disease activity protects the heart as well as the hands.

Untreated, most people develop erosions within two years and progressive deformity and disability over a decade; that trajectory is now largely preventable, but only with disease-modifying drugs, and this is the one point on which there is no honest ambiguity. Methotrexate, taken once weekly with daily folic acid, is the anchor drug and alone brings about a third of patients to low disease activity. If targets are not met within 3 to 6 months, a biologic (TNF inhibitors such as adalimumab or etanercept, IL-6 inhibitors, abatacept, rituximab) or a JAK inhibitor is added, which raises remission rates to roughly 40 to 60 percent. Treat-to-target care with regular disease activity scoring, started within three months of symptom onset, roughly doubles the chance of remission compared with delayed treatment. Short courses of prednisolone bridge flares. Infections are the main cost of these drugs, and JAK inhibitors carry additional cardiovascular and cancer warnings in older smokers after the ORAL Surveillance trial.

Natural approaches in rheumatoid arthritis are adjuncts to DMARD therapy, never alternatives, and the evidence is stronger than many doctors assume. Omega-3 fish oil is the standout: a meta-analysis of 17 trials found 2.7 g or more of EPA plus DHA daily reduced pain, morning stiffness and NSAID use after 3 months, and a 2015 Australian trial found 5.5 g daily alongside methotrexate-based triple therapy doubled remission and reduced treatment failure. A Mediterranean diet lowered disease activity scores by about 0.5 points and pain by 14 percent in a 12-week randomised trial. Curcumin, probiotics, vitamin D, ginger and cat's claw each have one or two small trials showing improved disease activity. Everything else is preliminary. The practical rule is to layer these onto treatment, tell your rheumatologist, and have liver tests monitored if you combine herbal extracts with methotrexate.

The most dangerous misconception is that feeling well means the disease has gone. Rheumatoid arthritis in remission on treatment is still rheumatoid arthritis, and stopping or tapering drugs without supervision leads to flare in roughly half of patients within a year, sometimes with damage that does not recover. The second is believing that an anti-inflammatory diet or supplement regimen can do the work of methotrexate; the people who try that during the first critical year lose the window in which joint destruction can be prevented. Diet, fish oil and exercise genuinely help, and they help most on top of adequate medical treatment.

At a Glance

Common symptoms
Tender, warm, swollen joints (typically symmetric, affecting both sides), Morning stiffness lasting more than 30–60 minutes, Joint pain and stiffness, particularly in the small joints of the hands and feet
Main treatments
Disease-modifying antirheumatic drugs (DMARDs) — methotrexate is first-line, Biologic DMARDs: TNF inhibitors (adalimumab, etanercept), IL-6 inhibitors (tocilizumab), B-cell depletion (rituximab), T-cell costimulation blockade (abatacept), JAK inhibitors (tofacitinib, baricitinib, upadacitinib)
Category
Autoimmune · About 1.3 million adults in the US; approximately 0.5–1% of the global population
See a doctor if
Persistent joint pain and swelling lasting more than 6 weeks

Symptoms

Tender, warm, swollen joints (typically symmetric, affecting both sides)
Morning stiffness lasting more than 30–60 minutes
Joint pain and stiffness, particularly in the small joints of the hands and feet
Fatigue and general malaise
Low-grade fever
Loss of appetite and weight loss
Rheumatoid nodules (firm bumps under the skin)
Dry eyes and mouth (secondary Sjögren syndrome)

Causes

  • Autoimmune attack on synovial tissue by the immune system
  • Genetic susceptibility (HLA-DR4 and other shared epitope alleles)
  • Environmental triggers (smoking, infections, hormonal factors)
  • Citrullinated protein autoimmunity (anti-CCP antibodies)

Risk Factors

  • Female sex (2–3 times more common in women)
  • Age 30–60 at onset
  • Smoking (strongest modifiable environmental risk factor)
  • Family history of RA
  • Obesity
  • Periodontal disease (Porphyromonas gingivalis linked to citrullination)

Diagnosis

  • 2010 ACR/EULAR classification criteria
  • Blood tests: rheumatoid factor (RF), anti-CCP antibodies, ESR, CRP
  • Joint X-rays showing erosions (may be normal early in the disease)
  • Ultrasound or MRI for early detection of synovitis and erosions
  • Synovial fluid analysis if needed

Treatment

  • Disease-modifying antirheumatic drugs (DMARDs) — methotrexate is first-line
  • Biologic DMARDs: TNF inhibitors (adalimumab, etanercept), IL-6 inhibitors (tocilizumab), B-cell depletion (rituximab), T-cell costimulation blockade (abatacept)
  • JAK inhibitors (tofacitinib, baricitinib, upadacitinib)
  • Short-term low-dose corticosteroids for flare management
  • NSAIDs for symptom relief
  • Physical and occupational therapy to maintain joint function

Natural remedies for rheumatoid arthritis: what the evidence says

Ranked by the strength of human evidence for rheumatoid arthritis specifically. These sit alongside medical care, not in place of it.

  1. A 2007 meta-analysis of 17 randomised trials found fish oil at 2.7 g or more of EPA plus DHA daily reduced patient-assessed joint pain, morning stiffness duration, number of tender joints and NSAID consumption after 3 to 4 months. In a 2015 trial of 140 people with early rheumatoid arthritis on methotrexate-based triple therapy, 5.5 g daily of EPA plus DHA produced remission in about twice as many patients and cut treatment failure compared with a low-dose control. Many patients can reduce their NSAID dose, which lowers stomach and kidney risk.

    Studied dose
    2.7 to 5.5 g combined EPA and DHA daily (typically 10 to 15 ml of concentrated liquid fish oil or 6 to 10 standard capsules) with meals, for at least 12 weeks.
    Cautions
    Increases bleeding tendency with warfarin, DOACs, aspirin and NSAIDs, so warn your doctor and stop a week before surgery. High doses may slightly raise LDL cholesterol and cause loose stools; use a product tested for oxidation and heavy metals, and note that fish oil does not reduce the need for DMARDs.
  2. In a 45-patient randomised trial, curcumin 500 mg twice daily for 8 weeks improved the DAS28 disease activity score and tender joint counts more than diclofenac 50 mg twice daily, with no dropouts for side effects. A 2021 trial of 24 patients found a bioavailable curcumin formulation lowered CRP, ESR and disease activity versus placebo over 90 days. The trials are small and short, so this is a promising adjunct rather than an established therapy.

    Studied dose
    500 mg twice daily of a bioavailable curcumin extract (phospholipid, micellar or piperine-enhanced) with food for 8 to 12 weeks.
    Cautions
    Potentiates anticoagulants and antiplatelet drugs. High-dose extracts have caused rare liver injury, which overlaps with the liver effects of methotrexate and leflunomide, so have liver enzymes checked at the routine 8 to 12 week DMARD blood test; may worsen reflux and gallstones.
  3. In a 60-patient randomised trial, a blend of Lactobacillus acidophilus, L. casei and Bifidobacterium bifidum at 2 billion CFU daily for 8 weeks lowered DAS28 by about 0.3 points, CRP and insulin levels versus placebo. An earlier 46-patient trial of L. casei 01 for 8 weeks reduced tender and swollen joint counts and inflammatory cytokines. A 2017 meta-analysis of nine trials found probiotics lowered CRP but produced inconsistent changes in disease activity.

    Studied dose
    Multi-strain Lactobacillus and Bifidobacterium product providing 1 to 10 billion CFU daily for at least 8 weeks.
    Cautions
    Avoid live probiotics if you are severely immunosuppressed (high-dose steroids plus a biologic, or neutropenia), have a central venous catheter, or have recent severe pancreatitis, because of rare bacteraemia. Bloating in the first week is common.
  4. Vitamin D

    Moderate evidence

    Low vitamin D is found in a majority of people with rheumatoid arthritis and correlates with higher disease activity and pain. Supplementation trials are mixed: a 2019 meta-analysis of six randomised trials found vitamin D modestly reduced disease activity and pain scores in deficient patients, while a large trial in people with recent-onset RA found no effect on activity but a lower risk of relapse. It is clearly worth correcting a deficiency, less clearly a treatment in its own right, and it protects bone from steroid-induced loss.

    Studied dose
    1,000 to 2,000 IU vitamin D3 daily, or higher short-term loading if the blood level is below 50 nmol/L, with calcium if on corticosteroids.
    Cautions
    Doses above 4,000 IU daily without monitoring can raise blood calcium, especially with thiazide diuretics or kidney disease; check a level after 3 months. No interaction with methotrexate or biologics.
  5. Ginger

    Preliminary evidence

    In a 2019 randomised trial of 70 patients with active rheumatoid arthritis on standard treatment, 1.5 g of ginger powder daily for 12 weeks reduced DAS28 by a significant margin versus placebo and lowered expression of inflammatory genes (NF-kappaB) while increasing regulatory T-cell markers. This is a single trial with a short follow-up; older evidence is mechanistic.

    Studied dose
    1.5 g dried ginger powder daily (about 750 mg twice daily) with food for 12 weeks.
    Cautions
    Mild antiplatelet effect adds to bleeding risk with anticoagulants, aspirin and NSAIDs; frequently causes heartburn. Large doses may lower blood sugar; safe in pregnancy at culinary doses.
  6. Cat's Claw (Uncaria tomentosa)

    Preliminary evidence

    In a 52-week trial of 40 patients already on sulfasalazine or hydroxychloroquine, a pentacyclic alkaloid-chemotype extract of cat's claw reduced the number of painful joints by 53 percent versus 24 percent on placebo during the first 24 weeks, without serious adverse effects. It is the only randomised trial, it was small, and the extract type matters because tetracyclic alkaloid chemotypes may antagonise the effect.

    Studied dose
    20 mg three times daily of a standardised pentacyclic oxindole alkaloid extract (as used in the trial), or 250 to 350 mg of dried bark extract daily.
    Cautions
    Immune-modulating, so discuss with your rheumatologist before combining with biologics or JAK inhibitors; theoretical additive immunosuppression or unpredictable immune activation. Avoid in pregnancy, before organ transplant, with low blood pressure, and with drugs metabolised by CYP3A4 such as ciclosporin and some statins.
  7. Boswellic acids inhibit 5-lipoxygenase and reduce leukotriene-driven inflammation, with solid trial evidence in osteoarthritis. In rheumatoid arthritis, however, the only randomised trial, a 1998 German study of 37 patients taking an H15 extract for 12 weeks, found no significant difference from placebo in disease activity or NSAID use. It ranks last here for that reason.

    Studied dose
    300 to 400 mg of extract standardised to 60 to 65 percent boswellic acids three times daily with food (the dose used in the RA trial).
    Cautions
    Can cause nausea, reflux and diarrhoea; may alter drug metabolism through CYP enzymes. Avoid in pregnancy and before surgery.

What matters day to day

  • Stop smoking: it roughly doubles the risk of developing rheumatoid arthritis, drives anti-CCP positive disease, and current smokers are about a third less likely to respond to methotrexate or TNF inhibitors.
  • Eat a Mediterranean pattern: in a 12-week randomised trial of 51 patients, a Cretan Mediterranean diet lowered DAS28 by about 0.5 points, pain by 14 percent and improved physical function compared with an ordinary Western diet.
  • Exercise despite the diagnosis: aerobic and resistance training improve fatigue, function and cardiovascular fitness without raising disease activity across dozens of trials, and high-intensity training reduced disease activity in a 2016 trial of 44 patients.
  • Treat gum disease: periodontitis is linked with RA onset through Porphyromonas gingivalis-driven citrullination, and non-surgical periodontal treatment lowered DAS28 and ESR in several small trials.
  • Protect your heart: RA raises cardiovascular risk by about 50 percent, so blood pressure, lipids and glucose should be checked yearly and risk calculators multiplied by 1.5 as EULAR recommends.

Prevention

  • No known prevention for RA, but risk can be reduced by:
  • Not smoking (smoking cessation reduces risk of developing RA)
  • Maintaining good oral health
  • Early treatment prevents joint damage (treat-to-target strategy)

When to See a Doctor

  • Persistent joint pain and swelling lasting more than 6 weeks
  • Morning stiffness lasting longer than 30 minutes
  • Symmetric joint involvement (same joints on both sides of the body)
  • Joint symptoms accompanied by fatigue, fever, or weight loss

Frequently Asked Questions

References

  1. Fraenkel L, Bathon JM, England BR, et al.. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care and Research (2021)
  2. Smolen JS, Landewé RBM, Bergstra SA, et al.. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Annals of the Rheumatic Diseases (2023)
  3. Proudman SM, James MJ, Spargo LD, et al.. Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use. Annals of the Rheumatic Diseases (2015)
  4. Goldberg RJ, Katz J. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain (2007)
  5. Sköldstam L, Hagfors L, Johansson G. An experimental study of a Mediterranean diet intervention for patients with rheumatoid arthritis. Annals of the Rheumatic Diseases (2003)
  6. Chandran B, Goel A. A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytotherapy Research (2012)
  7. Mur E, Hartig F, Eibl G, Schirmer M. Randomized double blind trial of an extract from the pentacyclic alkaloid-chemotype of Uncaria tomentosa for the treatment of rheumatoid arthritis. Journal of Rheumatology (2002)
  8. Shea B, Swinden MV, Tanjong Ghogomu E, et al.. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. Cochrane Database of Systematic Reviews (2013)
  9. Ytterberg SR, Bhatt DL, Mikuls TR, et al.. Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis (ORAL Surveillance). New England Journal of Medicine (2022)
  10. National Institute of Arthritis and Musculoskeletal and Skin Diseases. Rheumatoid Arthritis (2024)View source

Related Conditions

Related from the Supplement Library

These supplements have been studied in relation to Rheumatoid Arthritis. Always consult your healthcare provider before starting any supplement, especially if you take medications.

Have questions about Rheumatoid Arthritis?

Ask Mother Nature AI for personalized, evidence-based guidance.

Medical Disclaimer: This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.

Content reviewed against peer-reviewed medical literature and clinical guidelines. Read our editorial standards.